Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1975 Apr 1;141(4):761-74.

Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway

Comparative Study

Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway

B S Joseph et al. J Exp Med. .

Abstract

In these studies, a number of human cell lines including epithelial, neural, glial, and lymphoid cells infected with several strains of measles virus were found to be lysed upon incubation with fresh sera from humans containing antibody measles virus. In all instances, the cytolytic event was mediated by alternative complement (C) pathway without a significant contribution from classical pathway. In contrast, isolated measles virus in conjunction with antibody was found to selectively activate the classical C pathway. Measles antibodies of the IgG class, but not the IgA class, possessed cytolytic potential against cells infected with measles virus. Human IgG antibodies could directly activate the alternative C pathway. No defect was found in cytolytic measles antibody in sera or cerebrospinal fluid from patients with subacute sclerosing panencephalitis, nor was the alternative C pathway impaired in sera from these patients. Sera from newborn humans exhibited a functional alternative C pathway.

PubMed Disclaimer

References

    1. Cancer Res. 1963 Aug;23:1063-8 - PubMed
    1. Cancer Res. 1962 Sep;22:947-54 - PubMed
    1. Am J Dis Child. 1962 Mar;103:273-8 - PubMed
    1. Proc Soc Exp Biol Med. 1969 Jun;131(2):651-7 - PubMed
    1. J Immunol. 1973 May;110(5):1268-78 - PubMed

Publication types

MeSH terms